HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$2.23
Day range
$2.06 - $2.27
Year range
$1.91 - $22.22
Market cap
64.13M USD
Avg Volume
146.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 18.30M | 14.07% |
Net income | -16.62M | -8.44% |
Net profit margin | — | — |
Earnings per share | -0.56 | 29.11% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 114.21M | 29.03% |
Total assets | 121.26M | 33.13% |
Total liabilities | 10.66M | 24.47% |
Total equity | 110.60M | — |
Shares outstanding | 29.83M | — |
Price to book | 0.60 | — |
Return on assets | -35.18% | — |
Return on capital | -38.88% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -16.62M | -8.44% |
Cash from operations | -17.59M | -51.72% |
Cash from investing | 26.29M | 141.48% |
Cash from financing | 349.00K | 75.38% |
Net change in cash | 9.05M | 1,873.73% |
Free cash flow | -11.32M | -95.31% |
About
Founded
2017
Headquarters
Website
Employees
41